Previous studies have confirmed that GABA has anti-diabetic effects, which are mainly achieved by inhibiting obesity-related inflammation and upregulating Treg responses in vivo (32), and it was recently shown that GABA intervention can effectively protect mice from acute liver injury via GABA-mediated STAT3 signaling (33). Here, STAT3 is linked to obesity disorder.